OUR PARTNERS

OUR PARTNERS
Oxford Science Enterprises (OSE) is an independent, billion-pound investment company, created in 2015 to found, fund, and build transformational businesses through its unique partnership with the University of Oxford, the world’s number one research university.
This partnership enables OSE to work with the brightest academic minds tackling the world’s toughest challenges and guarantees unrivalled access to their scientific research.
In collaboration with its global network of entrepreneurs and advisers, OSE shapes and nurtures complex ideas into successful businesses. Actively focused on a core portfolio of around 40 companies spanning three high-growth, high-impact sectors – Life Sciences, Health Tech, and Deep Tech.
OES adopts a flexible, long-term investment approach, recognizing the path from ground-breaking research to global markets takes time and resilience.
To date, OSE has invested £0.5 billion in over 80 ambitious companies built on Oxford science. A key player in Oxford’s entrepreneurial ecosystem, OES is highly motivated to foster an environment that catalyzes pioneering research and steers it to commercial success.
JIMCO Life Sciences Fund participated in the 2022 funding round where OES raised a further £250 million (US$ 300 million) in funding bringing the total to more than £850 million (over US$ 1 billion) since inception in 2015.
Visit: Oxford Science Enterprises
For most of human history, even the tiniest of scratches could prove fatal. Never mind pneumonia, childbirth or surgery, gardening was a potentially deadly pursuit. A graze or scratch could become …
In medical lexicon ‘metabolic syndrome’ (MetS) might not exactly trip from the tongue like ‘heart disease’ or ‘cancer’. Yet, depending on where you live in the world, there could be a …
Forging a new model for cancer treatment: A Q&A with Professor R Charles Coombes, newly appointed special scientific advisor to Jameel Health.
Jameel Health is continually forging partnerships with leading organizations, researchers, innovators and thinkers in the global biotech and health industries. In 2021, it appointed Prof. James J. …
Healthcare – or rather adequate access to it – is one of the biggest challenges facing society today.
Despite the unprecedented levels of global wealth created by economic development over the past century, millions of people across vast regions of our planet are dying unnecessarily through poor …
The COVID-19 pandemic has been a stark reminder – if any were needed – of humankind’s persistent failure to address one of its most enduring, and potentially destabilizing, challenges – …
Health technology is transforming the way we can diagnose, treat and prevent disease, and has the potential to radically improve access to healthcare on a global scale.
From a longer-term historical perspective, the world we live in is undoubtedly fairer than it has ever been versus, say 100 years ago. In many – if not the majority – of countries across the …
Jameel Health appoints three globally respected scientists as special scientific advisors to join its mission in accelerating access to modern medical care across the global south.
©️ 2020-2023, Meddist Company Limited (Jameel Health). All rights in this Site are fully reserved. Permission to use this site is granted strictly subject to the Terms of Use. The Abdul Latif Jameel name, Jameel Health name; the Abdul Latif Jameel and Jameel Health logotypes and pentagon-shaped graphic are trademarks, or registered trademarks of Abdul Latif Jameel IPR Company Limited.
For medical incidence reporting please email: safety@jameelhealth.com or call +971 4 448 0905